A delay in US Food and Drug Administration officials learning of a report of unsafe bacterial contamination levels at a key infant formula plant in 2021 was a key reason behind the agency’s reorganization of its food safety programs.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?